CHRIS AMOS to Immunotherapy
This is a "connection" page, showing publications CHRIS AMOS has written about Immunotherapy.
Connection Strength
1.102
-
A refined use of mutations to guide immunotherapy decisions. Nature. 2022 12; 612(7941):639-641.
Score: 0.532
-
The tumor microenvironment of colorectal cancer metastases: opportunities in cancer immunotherapy. Immunotherapy. 2020 10; 12(14):1083-1100.
Score: 0.453
-
PI3K/Akt/mTOR Signaling and Plasma Membrane Proteins Are Implicated in Responsiveness to Adjuvant Dendritic Cell Vaccination for Metastatic Colorectal Cancer. Clin Cancer Res. 2017 Jan 15; 23(2):399-406.
Score: 0.085
-
A lepidic gene signature predicts patient prognosis and sensitivity to immunotherapy in lung adenocarcinoma. Genome Med. 2022 01 12; 14(1):5.
Score: 0.031